AE-19-ZK31_0.01uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=0.01uM, Prinomastat, Angiogenesis Inhibitors;MMP-9 (Gelatinase B) Inhibitors;MMP-2 (Gelatinase A) Inhibitors targeting MMP2, MMP9, MMP14, MMP11, MMP15, MMP16, MMP17, MMP19, MMP23A, MMP20, MMP27, MMP28, MMP21 (Novartis, 466151)
|
| External Link |
https://pubchem.ncbi.nlm.nih.gov/compound/466151
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
6 genes differentially expressed following the AE-19-ZK31_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
PQBP1
|
polyglutamine binding protein 1
|
1.50325
|
|
APRT
|
adenine phosphoribosyltransferase
|
0.784039
|
|
MCM4
|
minichromosome maintenance complex component 4
|
0.433343
|
|
TRMT112
|
tRNA methyltransferase 11-2 homolog (S. cerevisiae)
|
0.429373
|
|
TMEM258
|
transmembrane protein 258
|
0.334388
|
|
UBA52
|
ubiquitin A-52 residue ribosomal protein fusion product 1
|
0.225186
|